Patient Perspectives Throughout Peri-Implantitis Treatment

Sponsor
University of Barcelona
Study ID
NCT07694323
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

To evaluate longitudinal changes in oral health-related quality of life (OHRQoL) and other patient-reported outcomes (PROMs) throughout the different stages of peri-implantitis therapy, including diagnosis, non-surgical treatment, surgical treatment, and 6-month follow-up. Secondarily, to explore the influence of clinical, implant-related, and surgical factors on patient-reported outcomes and treatment experience.

Key Dates

First listed
Jul 9, 2026
Start date
Sep 3, 2026
Status verified
Jul 2026
Primary completion
Sep 3, 2027
Completion
Mar 30, 2028

Study Design

Enrollment
45 participants (estimated)

Arms

  • Arm: Peri-implantitis
    Inclusion Criteria Adult patients (≥18 years old) diagnosed with peri-implantitis according to the definition established by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018). Implants presenting bleeding on probing and/or suppuration, increased probing depth, and progressive bone loss compared with previous records. When previous records are unavailable, implants will be included if they present bleeding and/or suppuration on gentle probing, probing depth ≥ 6 mm, and a bone level ≥ 3 mm apical to the most coronal portion of the implant's rough surface. In patients requiring multiple surgical interventions, only the first surgical procedure will be included in the study.

Primary Outcome Measure

Change in Oral Health-Related Quality of Life (OHRQoL) [ Time Frame: T0 (immediately after diagnosis), T1 (6 weeks after non-surgical treatment), T2 (6 weeks after surgical treatment), and T3 (6 months after surgical treatment) ]

Central Contacts

Related Studies